WO2018003762A1 - 賦形剤及び錠剤 - Google Patents

賦形剤及び錠剤 Download PDF

Info

Publication number
WO2018003762A1
WO2018003762A1 PCT/JP2017/023475 JP2017023475W WO2018003762A1 WO 2018003762 A1 WO2018003762 A1 WO 2018003762A1 JP 2017023475 W JP2017023475 W JP 2017023475W WO 2018003762 A1 WO2018003762 A1 WO 2018003762A1
Authority
WO
WIPO (PCT)
Prior art keywords
tablet
excipient
powder
crystalline cellulose
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/023475
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
彰宏 富士野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Antivirus Res Inst Ltd
Original Assignee
Japan Antivirus Res Inst Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Antivirus Res Inst Ltd filed Critical Japan Antivirus Res Inst Ltd
Priority to JP2018525160A priority Critical patent/JP7020688B2/ja
Priority to CN201780040620.XA priority patent/CN109414051A/zh
Priority to US16/314,219 priority patent/US20190201345A1/en
Priority to KR1020197002187A priority patent/KR20190022709A/ko
Publication of WO2018003762A1 publication Critical patent/WO2018003762A1/ja
Anticipated expiration legal-status Critical
Priority to JP2022008665A priority patent/JP7239119B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02Starch; Degradation products thereof, e.g. dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/262Cellulose; Derivatives thereof, e.g. ethers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1535Five-membered rings
    • C08K5/1539Cyclic anhydrides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02Cellulose; Modified cellulose
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047Detergents in the form of bars or tablets
    • C11D17/0065Solid detergents containing builders
    • C11D17/0073Tablets
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/04Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
    • C11D17/041Compositions releasably affixed on a substrate or incorporated into a dispensing means
    • C11D17/042Water soluble or water disintegrable containers or substrates containing cleaning compositions or additives for cleaning compositions
    • C11D17/044Solid compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/221Mono, di- or trisaccharides or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/37Polymers
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D7/00Compositions of detergents based essentially on non-surface-active compounds
    • C11D7/22Organic compounds
    • C11D7/26Organic compounds containing oxygen
    • C11D7/268Carbohydrates or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/28Tabletting; Making food bars by compression of a dry powdered mixture
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to excipients and tablets.
  • a cleaning tablet in which the cleaning agent is in the form of a tablet and dissolved in water at the time of use.
  • Patent Document 1 includes a tablet: a) a first phase in the form of a molded body having at least one mold therein; and b) an adhesive in the mold.
  • a second phase in the form of a compressed body, wherein the tablet composition comprises one or more cleaning active ingredients that are concentrated primarily in the second phase, and the second phase additionally comprises a binder.
  • Multiphase wash tablets suitable for use in washing machines have been proposed.
  • powdered drugs may be spilled when the patient takes the drug, and the drug is tableted to ensure that the patient takes the amount of drug prescribed in the prescription. Yes.
  • the multiphase washed tablet of Patent Document 1 has a problem that it is insufficiently dissolved in water and requires time for dissolution in water.
  • the present invention relates to an excipient capable of rapidly disintegrating powders such as powdered detergents and powdered drugs in water or in the body and having excellent hardness, and tablets using this excipient. Provided pills.
  • the excipient of the present invention comprises One or more curing agents selected from the group consisting of maltitol, isomalt, maltose and lactose; Starch, It contains crystalline cellulose.
  • the powder can be easily tableted in a general manner.
  • the obtained tablet is excellent in the solubility with respect to water, and melt
  • the excipient of the present invention contains starch, crystalline cellulose, and one or more curing agents selected from the group consisting of maltitol, isomalt, maltose and lactose.
  • the excipient of the present invention is an excipient for tableting powder, and includes one or more curing agents selected from the group consisting of starch, crystalline cellulose, maltitol, isomalt, maltose and lactose. Containing.
  • the excipient contains starch.
  • the starch is not particularly limited and includes, for example, potato starch, sweet potato starch, corn starch, tapioca starch, wheat starch, rice starch, bean starch, kuzu starch, warabi starch, and potato starch.
  • a starch may be used independently or 2 or more types may be used together.
  • the excipient contains crystalline cellulose as a binder.
  • “Crystalline cellulose” refers to a product obtained by partially depolymerizing a natural cellulosic material with an acid, such as Metrolose, methylcellulose, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, hypromellose, and carmellose sodium. Can be mentioned.
  • Examples of natural cellulosic substances include cellulose obtained from plants such as wood, bamboo, wheat straw, rice straw, cotton, ramie, bagasse, kenaf and beet, cellulose obtained from sea squirts, and cellulose obtained from bacteria such as acetic acid bacteria. Etc.
  • a natural cellulosic substance may be used alone as a raw material, or two or more kinds may be used in combination. Crystalline cellulose may be used alone or in combination of two or more.
  • the average degree of polymerization of crystalline cellulose is preferably 500 or less.
  • the average degree of polymerization of crystalline cellulose can be measured by a reduced specific viscosity method using a copper ethylenediamine solution defined in the crystalline cellulose confirmation test (3) of “14th revised Japanese pharmacopoeia” (published by Yodogawa Shoten).
  • the average degree of polymerization of crystalline cellulose is preferably 10 to 500, more preferably 10 to 300. When the average degree of polymerization of crystalline cellulose is within the above range, a tablet obtained using an excipient has excellent disintegration properties in water or in the body.
  • Examples of a method for controlling the average degree of polymerization of crystalline cellulose include a hydrolysis treatment of a natural cellulose material.
  • a hydrolysis treatment By the hydrolysis treatment, the depolymerization of the amorphous cellulose inside the natural cellulosic substance proceeds, and the average degree of polymerization becomes small.
  • impurities such as hemicellulose and lignin are removed by the hydrolysis treatment, so that a crystalline cellulose having a porous natural cellulose-based material is obtained.
  • the method of hydrolysis is not particularly limited, and examples thereof include acid hydrolysis, hydrothermal decomposition, steam explosion, and microwave decomposition.
  • the particle shape (L / D) of crystalline cellulose is preferably 20 or less, more preferably 15 or less, further preferably 10 or less, further preferably 5 or less, particularly preferably less than 5, and most preferably 4 or less.
  • the lower limit of the crystalline cellulose particle shape (L / D) is 1 from its definition.
  • the particle shape (L / D) of crystalline cellulose refers to the value measured in the following manner.
  • crystalline cellulose is made into a pure water suspension having a concentration of 1% by mass, and a high shear homogenizer (for example, trade name “Excel Auto Homogenizer ED-7” manufactured by Nippon Seiki Co., Ltd.) is used for 5 minutes at a rotational speed of 15,000 rpm.
  • a water dispersion is produced by stirring over a period of time.
  • the aqueous dispersion is diluted with pure water to obtain a 0.1 to 0.5 mass% dispersion.
  • the dispersion is cast on mica, and the air-dried one is observed for crystalline cellulose with a high resolution scanning microscope (SEM) or atomic force microscope (AFM).
  • Extract 100 arbitrarily from the observed crystalline cellulose measure the major axis (L) and minor axis (D) in the observed direction of each crystalline cellulose to calculate the major axis (L) / minor axis (D),
  • the arithmetic average value of the major axis (L) / minor axis (D) of 100 crystalline celluloses is defined as the crystalline cellulose particle shape (L / D).
  • the major axis (L) and minor axis (D) of crystalline cellulose are measured in the following manner.
  • the content of crystalline cellulose in the excipient is preferably 5 to 20 parts by weight, more preferably 6 to 18 parts by weight, still more preferably 7 to 16 parts by weight, based on 100 parts by weight of starch, and 8 to 15 parts by weight. Is particularly preferable, and 8 to 12 parts by mass is most preferable.
  • the content of the crystalline cellulose is 5 parts by mass or more, the hardness of the tablet obtained using the excipient is improved.
  • the content of the crystalline cellulose is 20 parts by mass or less, the disintegration property of the tablet obtained using the excipient is improved.
  • the excipient contains at least one selected from the group consisting of maltitol, isomalt, maltose and lactose as a curing agent.
  • the curing agent preferably contains isomalt.
  • curing agent may be used independently or 2 or more types may be used together.
  • the curing agent preferably contains one or more compounds selected from the group consisting of maltitol, maltose, and lactose, and isomalt.
  • the content of the curing agent in the excipient is preferably 0.2 to 10 parts by weight, more preferably 0.3 to 8 parts by weight, and further preferably 0.5 to 5 parts by weight with respect to 100 parts by weight of starch. 0.6 to 3 parts by mass is particularly preferable, and 0.7 to 2 parts by mass is most preferable.
  • the content of the curing agent is 0.2 parts by mass or more, the hardness of the tablet obtained using the excipient is improved.
  • the content of the curing agent is 10 parts by mass or less, the disintegration property of the tablet obtained using the excipient is improved.
  • the excipient may contain additives such as a lubricant and an enzyme as long as the physical properties are not impaired.
  • a lubricant examples include calcium stearate, sodium stearate, potassium stearate, magnesium stearate and the like.
  • the excipient production method is not particularly limited as long as the constituent components can be uniformly mixed.
  • the excipient is produced by uniformly mixing starch, crystalline cellulose, and a curing agent using a general-purpose mixing apparatus. be able to.
  • Excipient is used to tablet the powder.
  • the powder is not particularly limited, and examples thereof include powdered detergents, powdered drugs, powdered seasonings, powdered foods, powdered health foods, and powdered health supplements (supplements). Can be mentioned.
  • a powder as a raw material and an excipient may be mixed and then tableted (tablet).
  • a method for tableting a powder using an excipient a known method can be used, and examples thereof include a direct tableting method and a dry granule compression method. Specifically, (1) The raw material powder and excipients and additives as necessary are mixed and then tableted (direct tableting method), (2) The raw material powder and excipient Examples thereof include a method in which a granule is prepared by mixing a shape agent and, if necessary, an additive, and the granule is tableted (dry granule compression method).
  • the ratio of the content of the powder as the raw material to the content of the excipient is: 6.4 or less is preferable.
  • the ratio of the content of the powder as the raw material to the content of the excipient is 0. .1 or more is preferable.
  • tablets obtained using the above excipients have excellent disintegration properties with respect to water, for example, when the powder is a cleaning agent, the tablets are simply put into a washing machine, for example. Since it can disintegrate quickly and dissolve the cleaning agent in water, the cleaning effect of the cleaning agent can be exhibited well.
  • the powder when the patient takes a tablet, the tablet is quickly disintegrated by the body fluid in the body, and the drug can be absorbed smoothly into the body to exhibit an excellent medicinal effect.
  • Examples 1 to 27, Comparative Examples 1 to 9 As starch, tapioca starch, corn starch, potato starch and rice starch, as crystalline cellulose, crystalline cellulose 1 (trade name “Seolas” manufactured by Asahi Kasei Chemicals), crystalline cellulose 2 (trade name “Hevaten 101” manufactured by Eiken Shoji Co., Ltd.) ) And crystalline cellulose 3 (trade name “Hevaten 102” manufactured by Eiken Shoji Co., Ltd.) and as a curing agent, isomalt, maltitol, maltose and lactose are supplied to the stirrer in predetermined amounts shown in Tables 1 and 2. The excipient was prepared by mixing uniformly.
  • Tablet composition by uniformly mixing 60 parts by mass of detergent (trade name “Attack” manufactured by Kao Corporation) or seasoning (trade name “Kunol Cup Soup” manufactured by Ajinomoto Co., Inc.) and 40 parts by mass of excipients as powder. Was made.
  • This tablet composition was supplied to a tableting machine to form tablets (thickness: 9 mm, weight: 3500 mg) at a tableting pressure of 14 kN by a direct tableting method.
  • the obtained tablet was put into 1 liter of water at 24.9 ° C.
  • the tablet was put into still water, and the water was stirred at a rotation speed of 60 rpm from the time when the tablet disintegrated 2/3 of its volume, and stirred until the tablet was completely disintegrated.
  • the time from when the tablet was put into still water until the tablet completely disintegrated was measured. If the tablet did not disintegrate even after 300 seconds had passed since it was put into still water, it was set as “Bad”.
  • the hardness of the obtained tablets was measured using a hardness meter (trade name “KIYA type hardness meter” manufactured by Fujiwara Seisakusho Co., Ltd.).
  • powders for example, detergents, drugs, seasonings, foods, health foods, health supplements (supplements), etc.
  • supplied for various applications
  • the obtained tablet rapidly disintegrates in water or the body and has excellent hardness.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Detergent Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Grain Derivatives (AREA)
PCT/JP2017/023475 2016-06-28 2017-06-27 賦形剤及び錠剤 Ceased WO2018003762A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2018525160A JP7020688B2 (ja) 2016-06-28 2017-06-27 賦形剤及び錠剤
CN201780040620.XA CN109414051A (zh) 2016-06-28 2017-06-27 赋形剂和片剂
US16/314,219 US20190201345A1 (en) 2016-06-28 2017-06-27 Excipient and tablet
KR1020197002187A KR20190022709A (ko) 2016-06-28 2017-06-27 부형제 및 정제
JP2022008665A JP7239119B2 (ja) 2016-06-28 2022-01-24 賦形剤及び錠剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016128150 2016-06-28
JP2016-128150 2016-06-28

Publications (1)

Publication Number Publication Date
WO2018003762A1 true WO2018003762A1 (ja) 2018-01-04

Family

ID=60785986

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/023475 Ceased WO2018003762A1 (ja) 2016-06-28 2017-06-27 賦形剤及び錠剤

Country Status (5)

Country Link
US (1) US20190201345A1 (cg-RX-API-DMAC7.html)
JP (2) JP7020688B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190022709A (cg-RX-API-DMAC7.html)
CN (1) CN109414051A (cg-RX-API-DMAC7.html)
WO (1) WO2018003762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4069203A1 (en) * 2019-12-06 2022-10-12 Synthon B.V. Pharmaceutical composition comprising eltrombopag bis(monoethanolamine)
CN111035620B (zh) * 2019-12-25 2021-08-27 广州莱可福生物科技有限公司 一种辅料组合物、植物甾醇复合营养素咀嚼片及其制备方法
US20220015993A1 (en) * 2020-07-14 2022-01-20 Johnson & Johnson Consumer Inc. Solid cleansing composition presenting controlled disintegration
CN113388341B (zh) * 2021-06-17 2023-09-15 安徽精公检测检验中心有限公司 一种固体粘结剂及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114376A1 (ja) * 2006-03-30 2007-10-11 Nippon Zoki Pharmaceutical Co., Ltd. 固形医薬製剤
JP2008037853A (ja) * 2006-08-01 2008-02-21 Higuchi Shokai:Kk イソマルトを含有する速崩壊性医薬品固形製剤
WO2010092828A1 (ja) * 2009-02-12 2010-08-19 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
WO2012001977A1 (ja) * 2010-06-29 2012-01-05 富士化学工業株式会社 崩壊性組成物及び易崩壊性圧縮成型物
WO2017142001A1 (ja) * 2016-02-16 2017-08-24 テイカ製薬株式会社 口腔内速崩壊性錠剤用造粒物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0979865T3 (da) 1998-07-17 2002-08-19 Procter & Gamble Detergenttablet
CN1768741A (zh) * 1999-05-21 2006-05-10 橘生药品工业株式会社 即释型口服用药物组合物
JP4588818B2 (ja) * 1999-09-16 2010-12-01 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
KR100496749B1 (ko) * 2000-07-05 2005-06-22 아사히 가세이 가부시키가이샤 셀룰로스 분말
ATE454132T1 (de) * 2003-01-21 2010-01-15 Nippon Shinyaku Co Ltd Rasch in der mundhöhle schmelzende tablette
JP5219508B2 (ja) * 2005-05-18 2013-06-26 大日本住友製薬株式会社 ドロキシドパを含有する安定な錠剤
EP2050448A4 (en) * 2006-08-08 2012-01-04 Kissei Pharmaceutical Mouth-dropping tray with masked bitter taste and method of preparation
EP2062599A4 (en) * 2006-09-14 2013-03-27 Astellas Pharma Inc ORAL DISSOLVING TABLET AND METHOD FOR THE PRODUCTION THEREOF
CA2715760C (en) * 2008-02-21 2017-06-13 Mitsubishi Tanabe Pharma Corporation Solid preparation for oral administration of cariprazine hydrochloride
WO2010025796A1 (en) * 2008-09-04 2010-03-11 Cargill Incorporated Tabletting of ervthritol
JO3753B1 (ar) * 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114376A1 (ja) * 2006-03-30 2007-10-11 Nippon Zoki Pharmaceutical Co., Ltd. 固形医薬製剤
JP2008037853A (ja) * 2006-08-01 2008-02-21 Higuchi Shokai:Kk イソマルトを含有する速崩壊性医薬品固形製剤
WO2010092828A1 (ja) * 2009-02-12 2010-08-19 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
WO2012001977A1 (ja) * 2010-06-29 2012-01-05 富士化学工業株式会社 崩壊性組成物及び易崩壊性圧縮成型物
WO2017142001A1 (ja) * 2016-02-16 2017-08-24 テイカ製薬株式会社 口腔内速崩壊性錠剤用造粒物

Also Published As

Publication number Publication date
JPWO2018003762A1 (ja) 2019-04-18
US20190201345A1 (en) 2019-07-04
JP7239119B2 (ja) 2023-03-14
JP2022051776A (ja) 2022-04-01
CN109414051A (zh) 2019-03-01
KR20190022709A (ko) 2019-03-06
JP7020688B2 (ja) 2022-02-16

Similar Documents

Publication Publication Date Title
JP7239119B2 (ja) 賦形剤及び錠剤
CN100465214C (zh) 纤维素粉末
JP2010507677A (ja) 錠剤処方物の賦形剤としての微結晶セルロースおよび糖アルコールの共処理物
Moreton Disintegrants in tableting
JP4361597B2 (ja) 崩壊剤、並びにそれが含まれた錠剤及び顆粒
JP6800596B2 (ja) 錠剤
JP2005187376A (ja) 低置換度セルロースエーテル含有カプセル及びその製造方法
JPWO2020026881A1 (ja) 崩壊剤成分及び微小繊維状セルロースを含む崩壊性固形物
JP4494000B2 (ja) 医薬用カプセル
CN104644594A (zh) 一种氢溴酸沃替西汀胃溶片及其制备方法
JP5644167B2 (ja) 溶出改善されたケトチフェン又はその塩を含有する固形製剤
WO2019131411A1 (ja) 口腔内崩壊錠用エリスリトール顆粒およびその製造方法ならびにそれを用いた口腔内崩壊錠
JP2004262860A (ja) キトサン含有錠剤及びその製造方法
JP7535520B2 (ja) メチルセルロースを含む徐放性組成物
JP3310233B2 (ja) 錠剤用崩壊剤
TW201113051A (en) Oral disintegrating tablet and manufacturing method thereof
JP2018012739A (ja) イルベサルタンを含有する錠剤
Azubuike et al. Investigation into some physico-technical and tableting properties of low-crystallinity powdered cellulose prepared from corn residues
KR20230086370A (ko) 다파글리플로진과 피오글리타존을 포함하는 약제학적 복합제제 및 이의 제조방법
JP3967767B1 (ja) 口腔内速崩錠の製造方法
WO2022172076A1 (en) Preparation of microwave dried novel co-processed excipient of sucrose and tablet formulation of canagliflozin tablets using co- processed excipient
JPS60139625A (ja) 固型薬剤の製法
TW201607556A (zh) 以二階段濕式造粒步驟製造之崩解性粒子組成物及含有該組成物之口腔內崩解錠劑
CN101528200A (zh) 干式制粒粘合剂,产品及其用途
JP6940356B2 (ja) N−アセチルグルコサミン錠剤

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2018525160

Country of ref document: JP

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17820116

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20197002187

Country of ref document: KR

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 17820116

Country of ref document: EP

Kind code of ref document: A1